Huadong Medicine Co., Ltd
000963
株式のランク
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
株価
$3.89
時価総額
$6.83B
変化（1日）
-2.22%
変化（1年）
-30.58%
国
CN
取引 Huadong Medicine Co., Ltd (000963)
カテゴリー
Healthcare
Huadong Medicine Co., Ltd（000963）のP/B比率
October 2026 時点のP/B比率 TTM: 1.79
Huadong Medicine Co., Ltd の最新の財務報告および株価によると、現在のP/B比率（TTM）は 1.79 です。2024 年末時点でのP/B比率は 2.63 でした。
Huadong Medicine Co., Ltd の P/B 比率の履歴（2001 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 1.79 | -35.76% |
| 2025 | 2.79 | 5.99% |
| 2024 | 2.63 | -23.81% |
| 2023 | 3.45 | -21.72% |
| 2022 | 4.41 | 3.89% |
| 2021 | 4.24 | 33.47% |
| 2020 | 3.18 | -8.27% |
| 2019 | 3.47 | -1.23% |
| 2018 | 3.51 | -44.06% |
| 2017 | 6.27 | 31.37% |
| 2016 | 4.77 | -60.08% |
| 2015 | 11.96 | 18.56% |
| 2014 | 10.09 | 29.56% |
| 2013 | 7.79 | 5.26% |
| 2012 | 7.40 | -1.93% |
| 2011 | 7.54 | -38.83% |
| 2010 | 12.33 | 73.78% |
| 2009 | 7.10 | 14.69% |
| 2008 | 6.19 | -52.76% |
| 2007 | 13.10 | 341.31% |
| 2006 | 2.97 | 36.69% |
| 2005 | 2.17 | -9.09% |
| 2004 | 2.39 | -0.72% |
| 2003 | 2.41 | -4.52% |
| 2002 | 2.52 | -3.19% |
| 2001 | 2.60 | 0.00% |
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| 1.9834 | 10.67% |
DE
|
|
| 2.1139 | 17.95% |
DE
|
|
| 1.3124 | -26.77% |
JP
|
|
| 6.3468 | 254.13% |
CH
|
|
| 5.0287 | 180.59% |
IN
|
